Get it to United States within 10 working days with standard delivery.

Fast delivery to United States

Easy Returns & Exchanges

Ask About This Product

Condition : New


From UAE

To United States

in 5-10 days


Tagrisso (osimertinib) is a medication used in the treatment of non-small cell lung cancer (NSCLC) that has a specific mutation known as epidermal growth factor receptor (EGFR) T790M mutation. It’s typically prescribed for patients who have progressed on previous EGFR tyrosine kinase inhibitor (TKI) therapy. The formulation you mentioned, Tagrisso 40 mg tablets, contains osimertinib as the active ingredient. Each tablet typically contains 40 mg of osimertinib along with other inactive ingredients. Osimertinib is classified as a third-generation EGFR tyrosine kinase inhibitor. It works by inhibiting the activity of mutated EGFR proteins, which are involved in the growth and spread of cancer cells in NSCLC. By targeting these mutated proteins, osimertinib helps to slow down or stop the growth of cancer cells, thereby aiding in the treatment of NSCLC. It’s important to take Tagrisso exactly as prescribed by your doctor. The dosage and duration of treatment may vary depending on factors such as the type and stage of cancer, your overall health, and other medications you may be taking. Always follow your doctor’s instructions carefully and report any side effects or concerns promptly.
Shopping Cart